Rabacfosadine Succinate
341 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
341
Total Reports
113
Deaths Reported
3310.0%
Death Rate
Active Ingredients
Rabacfosadine Succinate
Administration Routes
IntravenousUnknownParenteral
Species Affected
Dog 338
Cat 1
Human 1
Other Mammals 1
Most Affected Breeds
Retriever - Golden 37
Unknown 36
Retriever - Labrador 33
Boxer (German Boxer) 17
Shepherd Dog - German 16
Spaniel - Cocker American 12
Crossbred Canine/dog 11
Terrier - Bull - American Pit 10
Collie - Border 9
Poodle - Standard 8
Most Reported Reactions
Anorexia 109
Diarrhoea 99
Lethargy (see also Central nervous system depression in 'Neurological') 89
Weight loss 75
Death by euthanasia 75
Lack of efficacy - NOS 68
Elevated liver enzymes 46
Neutropenia 45
Vomiting 40
Alopecia 40
Neutrophilia 39
Thrombocytopenia 38
Outcome Breakdown
Outcome Unknown
133 (39.0%)
Euthanized
77 (22.6%)
Recovered/Normal
52 (15.2%)
Ongoing
37 (10.9%)
Died
36 (10.6%)
Recovered with Sequela
6 (1.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.